This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Contrarian Investing Led Me to Salix Pharmaceuticals

NEW YORK (TheStreet) -- Every successful investor is a contrarian: If the sum of all wisdom on a stock says it is worth $100 today, that price captures not just today's value but some future value as well.

If you buy it in the expectation that is it worth more than that -- worth more than what hundreds of thousands of other investors believe -- that is, by definition, a contrarian point of view.

I know very few people that are entirely invested in U.S. small and mid-cap stocks, such as Salix Pharmaceuticals (SLXP). But I am. Why? Because I believe that if you are in the right place at the right time, then the market is a beautiful place to be right now. U.S. small and mid-cap stocks have been the sweet spot for the past 15 months.

I track 34 asset classes on a daily basis including gold, bonds and emerging markets. Here is my current ranking.

Data from Best Stocks NowApp

Must Read: [video] Quick Take: Battle Brewing Between eBay and Carl Icahn

I see so many portfolios full of stocks that ran out of gas years ago. But they have big names and their CEOs says all the right things: Everything is going to get better. Just wait.

For them, investing is a faith-based initiative. I like value, performance and a good chart. My Best Stocks Now app tracks nearly 3,800 stocks. With so many to choose from, why do so many people choose the mediocre?

In addition to ranking asset classes, I rank 60 sectors in the market on a daily basis. Here is the current leader board.

Data from Best Stocks NowApp

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
SLXP $172.81 0.09%
FB $97.89 -5.90%
GOOG $666.01 -2.60%
TSLA $147.11 -9.50%
YHOO $26.90 -3.80%


Chart of I:DJI
DOW 15,825.16 -379.81 -2.34%
S&P 500 1,830.82 -49.23 -2.62%
NASDAQ 4,218.04 -145.1040 -3.33%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs